Peptide Research Guide

Peptide Research
Guide

Understanding Compounds, Mechanisms & Scientific Evidence

EVIDENCE & NOTES

This guide provides an educational overview of selected compounds discussed in peptide and related biomedical research. It summarizes how these compounds are classified, the biological pathways being investigated, and the current state of scientific evidence.

Research findings vary considerably by compound and study type. Laboratory, animal, and human research should be interpreted separately, and investigational findings should not be considered evidence of safety or effectiveness in humans.

Retatrutide

TRIPLE RECEPTOR AGONIST

BIOLOGICAL ROLE

Investigational agonist targeting GLP-1, GIP, and glucagon receptors involved in metabolic signaling and energy regulation.

RESEARCH AREAS

• Body-weight regulation
• Glucose metabolism
• Energy expenditure
• Cardiometabolic outcomes

EVIDENCE & NOTES

Investigational compound studied in human clinical trials. Not currently FDA-approved. Research continues into efficacy, safety, and longer-term outcomes.

TIRZEPATIDE

DUAL RECEPTOR AGONIST

BIOLOGICAL ROLE

Dual agonist targeting GIP and GLP-1 receptors involved in glucose regulation, appetite signaling, and metabolic processes.

RESEARCH AREAS

• Glucose metabolism
• Body-weight regulation
• Insulin sensitivity
• Cardiometabolic outcomes

EVIDENCE & NOTES

Studied extensively in human clinical trials. Tirzepatide has FDA-approved medical uses for specific indications. Research continues into additional metabolic and cardiovascular outcomes.

LIPO-B COMPLEX

NUTRIENT FORMULATION

BIOLOGICAL ROLE

Combination formulation containing nutrients and amino-acid-related compounds that may participate in metabolic pathways, nutrient processing, and normal cellular functions.

RESEARCH AREAS

• Nutrient metabolism
• Cellular energy pathways
• Amino acid metabolism
• Metabolic function

EVIDENCE & NOTES

Lipo-B Complex is a formulation rather than a peptide. Composition can vary between formulations, so evidence for individual ingredients should be distinguished from evidence for the combined product.

AOD-9604

GROWTH HORMONE FRAGMENT

BIOLOGICAL ROLE

Modified fragment of human growth hormone investigated for potential effects on lipid metabolism without reproducing the full biological activity of growth hormone.

RESEARCH AREAS

• Lipid metabolism
• Fat-cell biology
• Body composition
• Metabolic signaling

EVIDENCE & NOTES

Investigated in preclinical and human studies, but evidence supporting clinical effectiveness remains limited. AOD-9604 is not FDA-approved for weight loss or other therapeutic use.

MOTS-c

MITOCHONDRIAL-DERIVED PEPTIDE

BIOLOGICAL ROLE

Mitochondrial-derived peptide investigated for its role in cellular metabolic signaling, energy regulation, and responses to metabolic stress.

RESEARCH AREAS

• Cellular energy metabolism
• Glucose regulation
• Metabolic signaling
• Exercise physiology

EVIDENCE & NOTES

Much of the evidence remains preclinical. Human research is limited, and findings from laboratory or animal studies should not be assumed to produce the same effects in humans. MOTS-c is not FDA-approved for therapeutic use.

KLOW

MULTI-COMPOUND BLEND

GHK-Cu + BPC-157 + TB-500 + KPV

BIOLOGICAL ROLE

Combination formulation containing multiple research compounds associated with pathways involved in tissue remodeling, extracellular matrix activity, cellular signaling, and inflammatory processes.

RESEARCH AREAS

• Tissue repair mechanisms
• Skin and extracellular matrix biology
• Cellular signaling
• Inflammatory pathways

EVIDENCE & NOTES

KLOW is a combination formulation rather than a single peptide. Evidence varies among its individual components, and findings for an individual component should not be assumed to apply to the complete blend.

GLOW

MULTI-COMPOUND BLEND

GHK-Cu + BPC-157 + TB-500

BIOLOGICAL ROLE

Combination formulation containing research compounds associated with tissue remodeling, extracellular matrix activity, cellular signaling, and repair-related biological processes.

RESEARCH AREAS

• Tissue repair mechanisms
• Skin and extracellular matrix biology
• Collagen-related pathways
• Inflammatory and repair signaling

EVIDENCE & NOTES

GLOW is a combination formulation rather than a single peptide. Research evidence varies among its individual components, and findings for GHK-Cu, BPC-157, or TB-500 individually should not be assumed to apply to the combined formulation. The GLOW combination itself is not an FDA-approved therapeutic product.

WOLVERINE PEPTIDE

MULTI-COMPOUND BLEND

BPC-157 + TB-500

BIOLOGICAL ROLE

Combination formulation containing research peptides investigated for their potential roles in tissue-repair signaling, blood-vessel formation, cellular migration, and inflammatory processes.

RESEARCH AREAS

• Tissue repair mechanisms
• Tendon and ligament biology
• Angiogenesis and cellular migration
• Inflammatory signaling

EVIDENCE & NOTES

Wolverine Peptide is a combination formulation rather than a single peptide. Research on BPC-157 and TB-500 is primarily preclinical, and evidence for the combined formulation is limited. Findings from laboratory or animal research should not be assumed to produce the same effects in humans. The combination is not an FDA-approved therapeutic product.

GHK-Cu

COPPER-BINDING PEPTIDE

BIOLOGICAL ROLE

Naturally occurring copper-binding peptide involved in cellular signaling and processes associated with tissue remodeling, extracellular matrix regulation, and wound-repair biology.

RESEARCH AREAS

• Skin and extracellular matrix biology
• Collagen-related pathways
• Wound-repair mechanisms
• Hair follicle biology

EVIDENCE & NOTES

GHK-Cu has been investigated in laboratory, animal, and human research, particularly in areas involving skin and tissue biology. Evidence varies considerably by application and formulation. Findings from experimental research should not be interpreted as establishing effectiveness for all proposed uses. GHK-Cu is not FDA-approved as a drug for systemic therapeutic use.

BPC-157

SYNTHETIC PEPTIDE

BIOLOGICAL ROLE

Synthetic peptide investigated for its potential influence on cellular signaling involved in tissue repair, blood-vessel formation, inflammatory responses, and gastrointestinal tissue biology.

RESEARCH AREAS

• Tissue repair mechanisms
• Tendon and ligament biology
• Gastrointestinal tissue research
• Angiogenesis and inflammatory signaling

EVIDENCE & NOTES

BPC-157 has been studied primarily in laboratory and animal research. Human clinical evidence remains very limited, and findings from preclinical studies should not be assumed to produce the same effects in humans. BPC-157 is not FDA-approved for therapeutic use.

TB-500

THYMOSIN BETA-4–RELATED PEPTIDE

BIOLOGICAL ROLE

Synthetic peptide related to thymosin beta-4, a naturally occurring protein involved in cellular migration, actin regulation, blood-vessel formation, and tissue-repair processes.

RESEARCH AREAS

• Tissue repair mechanisms
• Cellular migration
• Angiogenesis
• Inflammatory and wound-healing pathways

EVIDENCE & NOTES

Research related to thymosin beta-4 includes laboratory, animal, and limited human studies. However, TB-500 should not be treated as interchangeable with naturally occurring thymosin beta-4. Clinical evidence specifically evaluating TB-500 in humans remains limited. TB-500 is not FDA-approved for therapeutic use.

KPV

α-MSH–DERIVED TRIPEPTIDE

BIOLOGICAL ROLE

Short peptide fragment derived from alpha-melanocyte-stimulating hormone (α-MSH) that is investigated for its influence on inflammatory signaling, immune responses, and epithelial tissue biology.

RESEARCH AREAS

• Inflammatory signaling
• Immune-response pathways
• Gastrointestinal and epithelial biology
• Tissue-response mechanisms

EVIDENCE & NOTES

KPV has been investigated primarily in laboratory and animal research, including studies involving inflammatory and gastrointestinal pathways. Human clinical evidence remains limited, and findings from preclinical research should not be assumed to produce the same effects in humans. KPV is not FDA-approved for therapeutic use.

CJC-1295 NO DAC + IPAMORELIN

GHRH ANALOG + GH SECRETAGOGUE

CJC-1295 no DAC + Ipamorelin

BIOLOGICAL ROLE

Combination of two compounds investigated for their effects on growth hormone signaling through different biological pathways. CJC-1295 no DAC acts through the GHRH receptor, while ipamorelin acts through the ghrelin receptor.

RESEARCH AREAS

• Growth hormone signaling
• GH and IGF-1 responses
• Metabolic regulation
• Body composition and recovery physiology

EVIDENCE & NOTES

The individual compounds have been investigated in preclinical and limited human research. Evidence for the combined formulation is more limited, and findings for either individual compound should not be assumed to apply to the combination. Neither compound is FDA-approved for therapeutic use.

TESAMORELIN

GHRH ANALOG

BIOLOGICAL ROLE

Synthetic analog of growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to increase endogenous growth hormone secretion and downstream IGF-1 signaling.

RESEARCH AREAS

• Growth hormone signaling
• Visceral adipose tissue
• Body composition
• Metabolic outcomes

EVIDENCE & NOTES

Tesamorelin has been studied in human clinical trials and has an FDA-approved medical use. Its approved indication is specifically for reducing excess abdominal fat in adults with HIV who have lipodystrophy. It is not FDA-approved for general weight loss or routine weight management.

SERMORELIN

GHRH ANALOG

BIOLOGICAL ROLE

Synthetic analog of growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland through the GHRH receptor, promoting endogenous growth hormone secretion.

RESEARCH AREAS

• Growth hormone signaling
• GH and IGF-1 responses
• Pituitary function
• Growth and metabolic physiology

EVIDENCE & NOTES

Sermorelin has been studied in humans and was previously FDA-approved as a diagnostic agent and for certain pediatric growth-related indications. Those FDA-approved products were later discontinued and are no longer marketed in the United States. Current uses or compounded formulations should not be interpreted as having FDA approval for anti-aging, body composition, or general wellness purposes.

IPAMORELIN

GROWTH HORMONE SECRETAGOGUE

BIOLOGICAL ROLE

Synthetic peptide that acts as an agonist of the ghrelin receptor (GHSR), stimulating signaling involved in growth hormone release from the pituitary gland.

RESEARCH AREAS

• Growth hormone signaling
• GH and IGF-1 responses
• Metabolic regulation
• Body composition and recovery physiology

EVIDENCE & NOTES

Ipamorelin has been investigated in preclinical research and limited human studies. Human clinical evidence remains limited, particularly for many of the broader wellness, body-composition, and recovery-related uses associated with the compound. Ipamorelin is not FDA-approved for therapeutic use.

NAD+

CELLULAR COENZYME

BIOLOGICAL ROLE

Naturally occurring coenzyme involved in cellular energy metabolism, redox reactions, DNA-repair processes, and cellular signaling.

RESEARCH AREAS

• Cellular energy metabolism
• Mitochondrial function
• DNA repair pathways
• Cellular aging and stress responses

EVIDENCE & NOTES

NAD+ is an essential molecule naturally present in human cells and is not a peptide. Its fundamental biological roles are well established. Research continues into whether altering NAD+ availability or metabolism may have clinical applications in aging, metabolic health, and other conditions. Evidence for specific NAD+ formulations and methods of administration should be evaluated separately.

DSIP

NEUROREGULATORY PEPTIDE

BIOLOGICAL ROLE

Naturally occurring peptide investigated for its potential involvement in sleep regulation, neuroendocrine signaling, stress responses, and central nervous system activity.

RESEARCH AREAS

• Sleep and circadian physiology
• Neuroendocrine signaling
• Stress-response pathways
• Central nervous system function

EVIDENCE & NOTES

DSIP has been investigated in laboratory, animal, and limited human research. Its biological role and mechanisms remain incompletely understood, and human evidence supporting many proposed effects is limited or inconsistent. DSIP is not FDA-approved for therapeutic use.

SEMAX

SYNTHETIC NEUROPEPTIDE ANALOG

BIOLOGICAL ROLE

Synthetic peptide derived from a fragment of adrenocorticotropic hormone (ACTH) and investigated for its influence on neurotrophic signaling, neuronal function, and responses to neurological stress.

RESEARCH AREAS

• Sleep and circadian physiology
• Neuroendocrine signaling
• Stress-response pathways
• Central nervous system function

EVIDENCE & NOTES

Semax has been investigated in laboratory, animal, and human research, including studies involving neurological and cognitive outcomes. However, the strength and availability of clinical evidence vary by proposed application, and much of the published human research originates outside the United States. Semax is not FDA-approved for therapeutic use

SELANK

SYNTHETIC NEUROPEPTIDE

BIOLOGICAL ROLE

Synthetic peptide investigated for its potential influence on neurotransmitter signaling, neuroendocrine activity, stress-response pathways, and cognitive processes.

RESEARCH AREAS

• Stress and anxiety-related pathways
• Neurotransmitter signaling
• Learning and memory
• Cognitive and neuroendocrine function

EVIDENCE & NOTES

Selank has been investigated in laboratory, animal, and limited human research, including studies involving anxiety, stress, and cognitive function. Human clinical evidence remains limited, and much of the available research originates outside the United States. Selank is not FDA-approved for therapeutic use.

PT-141

MELANOCORTIN RECEPTOR AGONIST

BIOLOGICAL ROLE

Synthetic peptide that activates melanocortin receptors in the central nervous system, where melanocortin signaling is involved in multiple neurological and physiological processes.

RESEARCH AREAS

• Melanocortin receptor signaling
• Sexual desire and arousal pathways
• Central nervous system signaling
• Behavioral and neuroendocrine responses

EVIDENCE & NOTES

Bremelanotide has been studied in human clinical trials and has an FDA-approved medical use. It is FDA-approved under the prescription drug Vyleesi for acquired, generalized hypoactive sexual desire disorder (HSDD) in certain premenopausal women. This approval is indication-specific and should not be interpreted as approval for other proposed uses of PT-141.